Horizon Therapeutics

Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Tue, 05/16/23 - 11:02 pm
Amgen
Horizon Therapeutics
M&A
FTC
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Tue, 05/16/23 - 12:17 pm
Amgen
Horizon Therapeutics
FTC
M&A
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
As Amgen's revenues slide, so too do sales at its big buyout target Horizon
Fierce Pharma
Wed, 05/3/23 - 10:29 pm
Amgen
earnings
Horizon Therapeutics
Viridian aims to prove itself in thyroid eye
EP Vantage
Thu, 04/20/23 - 10:41 am
Viridian Therapeutics
thyroid eye disease
Horizon Therapeutics
Tepezza
VRDN-001
Horizon's (HZNP) Tepezza Meets Goals in TED Expanded Use Study
Zacks.com
Tue, 04/11/23 - 11:28 am
Horizon Therapeutics
Tepezza
clinical trials
thyroid eye disease
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
Fierce Biotech
Tue, 03/21/23 - 10:00 am
Sobi
Selecta Biosciences
gout
SEL-212
Horizon Therapeutics
Krystexxa
Amgen bond offering to help fund Horizon Therapeutics acquisition
Seeking Alpha
Thu, 02/16/23 - 11:26 am
Amgen
bond
M&A
Horizon Therapeutics
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Mon, 01/30/23 - 10:41 am
Elizabeth Warren
Senate
FTC
M&A
Amgen
Horizon Therapeutics
Indivior
Opiant Pharmaceuticals
Horizon Bags Second Phase II Win in Sjögren’s Syndrome
BioSpace
Wed, 01/18/23 - 10:51 pm
Horizon Therapeutics
Sjögren’s syndrome
clinical trials
dazodalibep
Biopharma's stock market winners of 2022 revealed
EP Vantage
Wed, 01/18/23 - 09:46 am
pharma stocks
Merck
Eli Lilly
AbbVie
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Sarepta Therapeutics
Halozyme
Horizon Therapeutics
JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says
Fierce Pharma
Tue, 01/10/23 - 06:32 pm
JNJ
Horizon Therapeutics
M&A
Horizon enrolls first subject in Phase II trial of antibody for DLE treatment
Clinical Trials Arena
Thu, 01/5/23 - 10:17 am
Horizon Therapeutics
clinical trials
daxdilimab
DLE
discoid lupus
Billionaire John Paulson Stands To Make $500 Million From Horizon’s Sale To Amgen
Forbes
Wed, 12/14/22 - 07:22 pm
Amgen
M&A
Horizon Therapeutics
John Paulson
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx
Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
BioSpace
Mon, 12/12/22 - 10:34 am
Amgen
Horizon Therapeutics
M&A

Pages